On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

People’s Hospital of Rizhao

InstitutionResearch output, impact & collaborations

People’s Hospital of Rizhao is a institution indexed in ScholarIQ from OpenAlex.

What is known about People’s Hospital of Rizhao?

ScholarIQrecord summary

People’s Hospital of Rizhao is a research organisation in Rizhao, CN. OpenAlex records 3,668 works and 53,229 citations for it. 1,460 researchers list it as their most recent affiliation.

How many works does People’s Hospital of Rizhao have?

ScholarIQindexed works

People’s Hospital of Rizhao has 3,668 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does People’s Hospital of Rizhao have?

ScholarIQcitation count

People’s Hospital of Rizhao has 53,229 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at People’s Hospital of Rizhao?

ScholarIQresearcher count

People’s Hospital of Rizhao has 1,460 researchers in the ScholarIQ index.

What is the average h-index at People’s Hospital of Rizhao?

ScholarIQavg h-index

People’s Hospital of Rizhao has an average h-index of 33 in OpenAlex.

What is the ROR of People’s Hospital of Rizhao?

ScholarIQror

The ROR for People’s Hospital of Rizhao is on the source record.

What is the OpenAlex record for People’s Hospital of Rizhao?

ScholarIQopenalex

The OpenAlex for People’s Hospital of Rizhao is on the source record.

Who are the most-cited researchers behind People’s Hospital of Rizhao?

ScholarIQtop researchers by citations
1
Min Yu · Lung Cancer Treatments and Mutations
174 works3,455 citations

What are the most-cited papers on People’s Hospital of Rizhao?

ScholarIQmost cited works
Assessment of the expression of the immune checkpoint molecules PD‐1, CTLA4, TIM‐3 and LAG‐3 across different cancers in relation to treatment response, tumor‐infiltrating immune cells and survival
Lei Tu, Renguo Guan, Hanting Yang, Yu Zhou, Weifeng Hong, Liheng Ma, Guangzhe Zhao, Min Yu
International Journal of Cancer. 2019173 CitationsOPEN ACCESS
The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
Min Yu, Han Yongzhi, Shengying Chen, Xiaodan Luo, Ye Lin, Yu Zhou, Haosheng Jin, Baohua Hou, Yanying Deng, Lei Tu, Zhixiang Jian
Oncotarget. 2017170 CitationsOPEN ACCESS
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin, Min Yu, Tingting Ma, Chuanzhao Zhang, Shanzhou� Huang, Mohammad Reza Karimzadeh, Amir Abbas Momtazi‐Borojeni, Sheng Chen
Journal for ImmunoTherapy of Cancer. 2021156 CitationsOPEN ACCESS
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer
Limei Yin, Jianxin Xue, Rui Li, Lin Zhou, Lei Deng, Lin Chen, Yan Zhang, Yanying Li, Xuanwei Zhang, Weigang Xiu, Ruizhan Tong, Youling Gong, Meijuan Huang, Yong Xu, Jiang Zhu, Min Yu, Mengqian Li, Jie Lan, Jin Wang, Xianming Mo, Yuquan Wei, Gabriele Niedermann, You Lü
International Journal of Radiation Oncology*Biology*Physics. 2020143 Citations
KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming
Feifei Na, Xiangyu Pan, Jingyao Chen, Xuelan Chen, Manli Wang, Pengliang Chi, Liting You, Lanxin Zhang, Ailing Zhong, Lei Zhao, Siqi Dai, Mengsha Zhang, Yiyun Wang, Bo Wang, Jianan Zheng, Yuying Wang, Jing Xu, Jian Wang, Baohong Wu, Mei Chen, Hongyu Liu, Jianxin Xue, Meijuan Huang, Youling Gong, Jiang Zhu, Lin Zhou, Yan Zhang, Min Yu, Panwen Tian, Mingyu Fan, Zhenghao Lu, Zhihong Xue, Yinglan Zhao, Hanshuo Yang, Chengjian Zhao, Yuan Wang, Junhong Han, Shengyong Yang, Dan Xie, Lu Chen, Qian Zhong, Mu‐Sheng Zeng, Scott W. Lowe, You Lü, Yu Liu, Yuquan Wei, Chong Chen
Nature Cancer. 2022123 CitationsOPEN ACCESS

How much of the research on People’s Hospital of Rizhao is open access?

ScholarIQopen access share
91%OPEN ACCESS
Gold
55%
Green
18%
Hybrid
9%
Bronze
9%
Closed
9%

Related on ScholarIQ

470M+ articles · 14-day free trial